As of 2025-09-18, the Intrinsic Value of Edgewise Therapeutics Inc (EWTX) is -7.15 USD. This EWTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 13.70 USD, the upside of Edgewise Therapeutics Inc is -152.21%.
Based on its market price of 13.70 USD and our intrinsic valuation, Edgewise Therapeutics Inc (EWTX) is overvalued by 152.21%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -7.15 - -7.15 | -7.15 | -152.21% |
| P/E | (27.21) - (28.41) | (28.04) | -304.7% |
| DDM - Stable | (16.25) - (64.81) | (40.53) | -395.9% |
| DDM - Multi | (0.24) - (0.70) | (0.35) | -102.6% |
| Market Cap (mil) | 1,443.30 |
| Beta | 2.34 |
| Outstanding shares (mil) | 105.35 |
| Enterprise Value (mil) | 1,399.89 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.07% |
| Cost of Debt | 5.00% |
| WACC | 5.98% |